Announcements Trials
Browse Landscape

Phase

Phase 2 16Phase 1/2 7Phase 3 6Phase 2/3 5Phase 1 3Phase 4 2Phase NA 1Phase EARLY_PHASE1 1

Status

Recruiting 16Completed 14Active not recruiting 14Not yet recruiting 6Terminated 4Unknown 2

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

Other hematologic neoplasm 6Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 6Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1

Interventions

Paclitaxel 24Oxaliplatin 24Capecitabine 24Gemcitabine 21Cisplatin 21Fluorouracil 20Drug Therapy 18Docetaxel 18Carboplatin 17pembrolizumab 15Leucovorin 15Irinotecan 15Radiotherapy 12tislelizumab 11Magnetic Resonance Spectroscopy 10Bevacizumab 10Specimen Handling 9Pemetrexed 9Radiation 8Injections 8Cetuximab 8toripalimab 7Surgical Procedures, Operative 7Radiotherapy, Intensity-Modulated 7Azacitidine 7venetoclax 6sintilimab 6Trastuzumab 6Topotecan 6Standard of Care 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 3 × Not yet recruiting × venetoclax × Clear all
NCT07469046 2026-04-13

VAH vs VA in Newly Diagnosed Elderly AML

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Phase 3 Not yet recruiting
308 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT07407140 2026-03-25

VAG-3+7-G

Institute of Hematology & Blood Diseases Hospital, China

Phase 3 Not yet recruiting
300 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT07486479 2026-03-20

Venetoclax, Azacitidine, and Mitoxantrone Hydrochloride Liposome Versus Idarubicin and Cytarabine in Newly Diagnosed AML

The First Affiliated Hospital of Soochow University

Phase 3 Not yet recruiting
204 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT07478991 2026-03-18

VENP-A-QUI

PETHEMA Foundation

Phase 3 Not yet recruiting
376 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT07407660 2026-02-12

Shortened Venetoclax Duration Based on Day 14 BM Blasts Versus Standard Therapy in Elderly or Frail Patients With AML Patients Treated With Azacitidine Plus Venetoclax

Peking University People's Hospital

Phase 3 Not yet recruiting
250 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT07082452 2025-07-24

SEVENAZA

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Not yet recruiting
262 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡